Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Minoxidil significantly lowers blood pressure in patients with hard-to-treat hypertension, but can cause fluid retention and excessive hair growth.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

New drug uses show promise but need more research.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Baricitinib is the most effective treatment for alopecia areata.

Prescription tablets treat hirsutism, while over-the-counter foams treat hypertrichosis.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Baricitinib may effectively treat oral lichen planus.

Methotrexate may help stabilize frontal fibrosing alopecia.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.